The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Welcome to The Lymphoma Channel
VJHemOnc brings you key updates in aggressive NK- and T-cell lymphomas directly from leading researchers. The Aggressive T-cell & NK-cell Lymphoma Channel covers pivotal updates presented at major international congresses so that you can stay up-to-date through video interviews, podcasts and roundtable discussions with leading experts.
